Better Evaluation of Acute Chest Pain With Computed Tomography Angiography (BEACON)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01413282|
Recruitment Status : Completed
First Posted : August 10, 2011
Last Update Posted : August 4, 2016
|Condition or disease||Intervention/treatment||Phase|
|Acute Coronary Syndrome Acute Chest Pain||Radiation: Cardiac CT||Not Applicable|
Myocardial infarction remains one of the most important causes of death and disability. Therefore it is important that individuals with acute chest pain are accurately assessed without delaying appropriate treatment. Acute coronary syndrome is only one cause for sudden chest pain, which is a very common complaint in the ER. Other life threatening causes such as pulmonary embolism and aortic dissection may also be the cause, although most chest discomfort has a benign reason (musculoskeletal, hyperventilation, oesophageal reflux, etc).
The current work-up of suspected acute coronary syndrome, based on presentation, symptoms, ECG and biomarkers, is not efficient and results in unnecessary diagnostics and hospital admissions, as well as errors or delayed diagnoses, in a substantial number of patients. Computed tomography angiography (CTA) images atherosclerosis, coronary obstruction as well as myocardial hypoperfusion. We hypothesize that early use of CTA is of incremental value and allows for accurate and immediate triage of patients with acute chest pain.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||500 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Better Evaluation of Acute Chest Pain With Computed Tomography Angiography - A Randomized Controlled Trial|
|Study Start Date :||July 2011|
|Actual Primary Completion Date :||February 2014|
|Actual Study Completion Date :||February 2015|
Active Comparator: Cardiac CT
Triage based on cardiac CT results.
Radiation: Cardiac CT
Calcium scan and CT coronary angiography
No Intervention: Standard Care
Standard diagnostic management according to the European guidelines.
- Successful discharge rate [ Time Frame: 30 days ]The proportion of patients discharged home without major adverse events during the following 30 days. Major adverse events are cardiovascular death or non-fatal myocardial infarction.
- Diagnostic yield of invasive angiography [ Time Frame: 30 days ]Number of patients identified with severe coronary artery disease identified by invasive angiography requiring revascularisation according to the international guidelines.
- Successful discharge rate for all adverse events [ Time Frame: 30 days ]The proportion of patients discharged home without any adverse events during the following 30 days. Adverse events are cardiovascular death, non-fatal myocardial infarction, unstable angina, coronary revascularization, repeat hospital visits for chest pain.
- Major adverse events [ Time Frame: 6 months ]Composite endpoint of major adverse cardiac events at 6 months: cardiovascular death, non-fatal myocardial infarction, unstable angina, coronary revascularisation and repeat hospital visits for chest pain.
- Acute coronary syndrome [ Time Frame: Index hospital visit ]Diagnosis of acute coronary syndrome, according to international guidelines, at time of discharge.
- Missed myocardial infarctions [ Time Frame: 2 days ]Missed myocardial infarctions, at 2-day follow-up, in patients discharged from the emergency department.
- Duration of hospital stay [ Time Frame: Index hospital visit ]Duration of hospital stay
- Direct medical cost [ Time Frame: 30 days ]Direct medical costs until 30th day after ED visit.
- Radiation exposure [ Time Frame: 6 months ]Cumulative medical radiation exposure at 6 months.
- Renal function [ Time Frame: 2 days ]Change in renal function after 2 days.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01413282
|Principal Investigator:||Koen Nieman, MD, PhD||Erasmus MC|